Core Viewpoint - Plaid Technologies Inc. has appointed Dr. Ian Flint as a Technical Advisor to enhance its graphene-enabled technologies and support their commercialization efforts [1][5]. Group 1: Appointment of Dr. Ian Flint - Dr. Flint has over 30 years of experience in process development, pilot plant design, and industrial-scale operations, with a focus on graphite and graphene technologies for more than 15 years [2]. - His career includes roles in mineral processing, teaching engineering, and leading projects in graphite and graphene development, as well as founding two technology startups [3]. - In his advisory role, Dr. Flint will focus on process optimization, scale-up readiness, and transitioning from laboratory work to commercial production [4]. Group 2: Company Strategy and Goals - Plaid is positioned at the intersection of advanced materials and industrial applications, aiming to leverage graphene for significant value [5]. - The CEO of Plaid, Guy Bourgeois, emphasized that Dr. Flint's expertise aligns with the company's objectives to advance graphene-enabled solutions into field testing and market adoption [5]. - The company aims to develop scalable and commercially viable graphene solutions for large industrial markets, enhancing its technical depth through Dr. Flint's appointment [5]. Group 3: Stock Options Granted - The company has granted Dr. Flint 75,000 stock options at an exercise price of $0.94 per share, which will vest quarterly over 12 months [6]. - These options are part of the company's long-term incentive plan approved by shareholders on October 30, 2025 [6].